StockData
BioLineRx Ltd. logo

BioLineRx Ltd. (BLRX) stock

BLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 23, 2026Score 3/30
$1.12−0.03 (-2.61%)

Close on Nov 17, 2026Market cap $4.87MP/E –Yield –

BioLineRx price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BioLineRx's price to book ratio was 0.4× on Nov 11, 2026, against 0.8× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−0.1
2025Jul 31, 20250.6×–

More BioLineRx figures

See a number that looks wrong?